Segment information - Adjustment to EBITDA (Details) - BRL (R$) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Notes and other explanatory information [abstract] | |||
| Gain on fair value adjustments (Note 29) | R$ 1,516,458,000 | R$ 1,431,530,000 | R$ 1,989,831,000 |
| Loss from associates and joint ventures | (409,212,000) | (13,845,000) | (19,379,000) |
| Impairment loss (reversal of impairment loss) recognised in profit or loss | 88,871,000 | ||
| Income from disposal and write-off of non-current assets | 386,396,000 | 169,284,000 | 232,143,000 |
| Provision/(reversals) for losses on ICMS credits (note 9.1) | 193,152,000 | 130,726,000 | 348,628,000 |
| Expenses on Asset Acquisition and Business Combinations | (82,426,000) | (34,065,000) | (25,171,000) |
| Write-off of wood inventory | (78,203,000) | (11,930,000) | (22,998,000) |
| Restructuring expenses | (59,725,000) | (1,205,000) | (8,974,000) |
| Other | 8,526,000 | 4,588,000 | 68,110,000 |
| Adjustments to EBITDA | R$ 209,947,000 | R$ 1,065,887,000 | R$ (1,264,428,000) |
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Accrual for ICMS Credit Losses No definition available.
|
| X | ||||||||||
- Definition Adjustment to EBITDA, Other No definition available.
|
| X | ||||||||||
- Definition Adjustments to EBITDA No definition available.
|